ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Janux Therapeutics Inc

Janux Therapeutics Inc (JANX)

44,11
3,93
(9,78%)
Geschlossen 25 Januar 10:00PM
40,00
-4,11
( -9,32% )
Vor Marktöffnung: 11:19AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
40,00
Gebot
40,12
Fragen
61,93
Volumen
421
0,00 Tagesbereich 0,00
7,79 52-Wochen-Bereich 71,71
Marktkapitalisierung
Handelsende
44,11
Handelsbeginn
-
Letzte Trade
2
@
42.48
Letzter Handelszeitpunkt
11:19:10
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.168.029
Ausgegebene Aktien
52.482.020
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-39,71
Gewinn pro Aktie (EPS)
-1,11
Erlöse
8,08M
Nettogewinn
-58,29M

Über Janux Therapeutics Inc

Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Janux Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker JANX. The last closing price for Janux Therapeutics was US$44,11. Over the last year, Janux Therapeutics shares have traded in a share price range of US$ 7,79 to US$ 71,71.

Janux Therapeutics currently has 52.482.020 shares in issue. The market capitalisation of Janux Therapeutics is US$2,31 billion. Janux Therapeutics has a price to earnings ratio (PE ratio) of -39.71.

JANX Neueste Nachrichten

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.605-3.8577094099341.60545.4439.33129105841.72610379CS
4-13.22-24.840285606953.2261.5939.33118164048.13054655CS
12-13.5-25.233644859853.571.7139.33116802954.4753151CS
26-4.08-9.2558983666144.0871.7134.512584153551.22616127CS
5230.64327.350427359.3671.717.7985433248.40818702CS
15625.6177.77777777814.471.715.6534639941.87237494CS
260617.64705882353471.715.6531740440.1719618CS

JANX - Frequently Asked Questions (FAQ)

What is the current Janux Therapeutics share price?
The current share price of Janux Therapeutics is US$ 40,00
How many Janux Therapeutics shares are in issue?
Janux Therapeutics has 52.482.020 shares in issue
What is the market cap of Janux Therapeutics?
The market capitalisation of Janux Therapeutics is USD 2,31B
What is the 1 year trading range for Janux Therapeutics share price?
Janux Therapeutics has traded in the range of US$ 7,79 to US$ 71,71 during the past year
What is the PE ratio of Janux Therapeutics?
The price to earnings ratio of Janux Therapeutics is -39,71
What is the cash to sales ratio of Janux Therapeutics?
The cash to sales ratio of Janux Therapeutics is 286,43
What is the reporting currency for Janux Therapeutics?
Janux Therapeutics reports financial results in USD
What is the latest annual turnover for Janux Therapeutics?
The latest annual turnover of Janux Therapeutics is USD 8,08M
What is the latest annual profit for Janux Therapeutics?
The latest annual profit of Janux Therapeutics is USD -58,29M
What is the registered address of Janux Therapeutics?
The registered address for Janux Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Janux Therapeutics website address?
The website address for Janux Therapeutics is www.januxrx.com
Which industry sector does Janux Therapeutics operate in?
Janux Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ONCOOnconetix Inc
US$ 0,9797
(104,10%)
20,87M
HWHHWH International Inc
US$ 0,515
(79,01%)
14,41M
WMPNWilliam Penn Bancorporation
US$ 19,66
(58,55%)
57
TVGNTevogen Bio Holdings Inc
US$ 2,125
(57,41%)
15,6M
TWINTwin Disc Inc
US$ 16,99
(49,69%)
5
DSGNDesign Therapeutics Inc
US$ 2,00
(-59,76%)
102
ATLOAmes National Corporation
US$ 7,15
(-59,74%)
45
NODKNI Holdings Inc
US$ 6,01
(-58,58%)
7
TBNKTerritorial Bancorp Inc
US$ 5,00
(-44,99%)
211
MDXGMiMedx Group Inc
US$ 5,10
(-41,98%)
101
ONCOOnconetix Inc
US$ 0,9814
(104,46%)
20,9M
TVGNTevogen Bio Holdings Inc
US$ 2,13
(57,78%)
15,65M
HWHHWH International Inc
US$ 0,515
(79,01%)
14,42M
NVDANVIDIA Corporation
US$ 128,06
(-10,21%)
12,23M
ACONAclarion Inc
US$ 0,0416
(-24,23%)
6,05M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock